The use of tumour necrosis factor alpha-blockers in daily routine. An Austrian consensus project

To define relevant disease parameters and their respective limits indicating the initiation of TNF-α-blockers in individual patients. Subsequently, to analyze retrospectively patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) or ankylosing spondylitis (AS), who started TNF-α inhibiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Leeb, Burkhard F., Böttcher, Elke, Brezinschek, Hans-Peter, Czerwenka, Christoph, Herold, Manfred, Hitzelhammer, Hans, Mayrhofer, Franz, Puchner, Rudolf, Rainer, Franz, Rintelen, Bernhard, Schirmer, Michael, Stuby, Ulrike, Bröll, Hans
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797412/
https://www.ncbi.nlm.nih.gov/pubmed/19904485
http://dx.doi.org/10.1007/s10067-009-1304-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797412/
https://www.ncbi.nlm.nih.gov/pubmed/19904485
http://dx.doi.org/10.1007/s10067-009-1304-y

Ejemplares similares